Acer set to unveil cloud-based remote healthcare solutions at CES
Taiwan-based PC manufacturer Acer is set to unveil a large range of cloud-based healthcare solutions behind its Build Your Own Cloud (BYOC) partners at the Consumer Electronics Show (CES).
At the annual show in Las Vegas, Acer intends to showcase its complete healthcare solutions, which are expected to integrate software and hardware elements. In addition, the company displayed solutions based upon the Acer Open Platform (AOP) with its hardware partners, as application cover everything from health monitoring to remote diagnostics.
RELATED TOPIC: Why the cloud is the safest place to store medical records
“Healthcare has always been a focus of BYOC development,” said BYOC president Maverick Shih. “We expect that long-term healthcare will be a key area in the development of healthcare technology.”
The solutions set to be demonstrated include health monitoring and remote diagnostics. With health monitoring, patients can measure their vital signs or home air quality daily through blood pressure and air quality monitors. This data can be continuously recorded and uploaded to a management platform through the AOP for medical professionals to analyze.
RELATED TOPIC: 4 reasons to take your medical records to the cloud
Meanwhile, remote diagnostics are for those who don’t require intensive medical attention, but still need to be monitored for extended periods. This allows them to interact with medical professionals through smart devices or interactive telepresence equipment for remote diagnostic purposes. Here, vital signs such as blood pressure and blood sugar can be uploaded to a management platform through AOP for recording and analysis.
Acer is working alongside partners in the healthcare sector for the BYOC showcase, which include medical device manufacturer Omron Corp and indoor air quality monitoring device producer CoAsia Microelectronics Corp.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”